FDA vaccine chief to leave the agency again
Source: SeekingAlpha
2026-03-07 07:41:45 ET
More on Pfizer, Johnson & Johnson, etc.
- Pfizer: Obesity Hype And Vaccine Policy Shocks
- The Sun Will Shine On Moderna Again - Initiating With A Buy
- Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom
- J&J subsidiaries ink $65M deal to resolve Tracleer antitrust case
- Pharma giants pressed by Senate Democrats over Trump pricing deals
Read the full article on Seeking Alpha
For further details see:
FDA vaccine chief to leave the agency again
Bristol-Myers Squibb Company
NASDAQ: BMY
BMY Trading
-1.51% G/L:
$58.94 Last:
4,275,253 Volume:
$59.17 Open:
BMY Latest News
March 09, 2026 06:59:00 am
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
BMY Stock Data
$123,325,918,376
2,034,328,000
N/A
1394
N/A
Pharmaceuticals
Healthcare
US
Princeton
